Skip to main content
SoftOx Solutions AS logo

SoftOx Solutions AS — Investor Relations & Filings

Ticker · SOFTX ISIN · NO0010811961 LEI · 549300AETMWJS91G4A50 OL Manufacturing
Open in API
Filings indexed 572 across all filing types
Latest filing 2022-12-02 AGM Information
Country NO Norway
Listing OL SOFTX

About SoftOx Solutions AS

https://soft-ox.com/

SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.

Recent filings

Filing Released Lang Actions
SoftOx Solutions AS: Notice of Extraordinary General Meeting
AGM Information Classification · 98% confidence The document is explicitly titled 'Notice of Extraordinary General Meeting' and discusses the convening of an EGM for the election of a new chairman and board members. This directly relates to shareholder meetings and the proposals being put forward for a vote. While it announces a meeting, the content focuses heavily on the proposed changes to the board structure and the rationale behind them, which is a key component of materials presented to shareholders before a vote. This aligns best with the definition of materials shared during a general meeting (AGM-R, although this is an EGM) or materials soliciting a vote (PSI). Since it is a formal 'Notice' detailing the agenda items (election of chair/board, remuneration) and the proposals, it is most closely related to the materials used to inform shareholders for voting purposes. However, the core event being announced is the Extraordinary General Meeting itself, which is analogous to an AGM. Given the options, 'AGM-R' (AGM Information) is the closest fit for materials related to a General Meeting, even if it's an EGM, as it details the proposals being voted on. If the document were purely soliciting votes without detailing the meeting structure, PSI might fit, but this is the formal notice of the meeting itself.
2022-12-02 English
SoftOx Solutions AS: Mandatory notification for close associate
Director's Dealing Classification · 100% confidence The document text is titled 'KRT-1500 Skjema for melding om transaksjoner utført av personer med ledelsesansvar («primærinnsidere») og deres nærstående' (Form KRT-1500 for reporting transactions carried out by persons discharging managerial responsibilities ('insiders') and their close associates). It details a transaction (Salg/Sale) by an insider (GEIR HERMOD ALMÅS, Adm dir) involving a financial instrument on 03.11.2022. This structure and content directly correspond to regulatory filings reporting insider trading or director's dealings. Among the provided codes, 'Director's Dealing (Code: DIRS)' is the most specific match for reporting personal share transactions by company directors and executives.
2022-11-03 Norwegian
SoftOx Solutions AS: Mandatory notification for close associate
Director's Dealing Classification · 98% confidence The document is a short notification (1245 characters) regarding a transaction involving a person discharging managerial responsibilities (CEO Geir H. Almås) in SoftOx Solutions AS. It explicitly mentions a 'Mandatory notification for close associate' and refers to an 'attached form for further details about the transfer.' This structure—a brief announcement pointing to an attached/detailed document about insider transactions—strongly suggests a Director's Dealing report. Although it references MAR regulations, the specific content points directly to insider trading disclosure, which corresponds to the Director's Dealing category (DIRS). It is not a general regulatory filing (RNS) because it is highly specific to insider transactions.
2022-11-03 English
SOFTOX SOLUTIONS: THIRD QUARTER 2022 RESULTS
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly report' for Q3 2022 and contains comprehensive financial data, including a balance sheet, income statement, and management discussion of business operations, clinical trials, and product development. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2022
2022-10-26 English
SOFTOX SOLUTIONS: THIRD QUARTER 2022 RESULTS
Investor Presentation Classification · 98% confidence The document text explicitly states it is a 'Presentation Q3 2022' dated '26 October 2022'. It contains detailed slides covering R&D highlights, commercial development, financial review (Q3 result of NOK -23.7 million), product pipeline, and technology overview. This structure is characteristic of an Investor Presentation (IP) used to communicate quarterly performance and strategy to investors, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). Since it is a comprehensive presentation detailing results and outlook, Investor Presentation (IP) is the most appropriate classification.
2022-10-26 English
SOFTOX SOLUTIONS: THIRD QUARTER 2022 RESULTS
Earnings Release Classification · 100% confidence The document is explicitly titled 'SOFTOX SOLUTIONS: THIRD QUARTER 2022 RESULTS' and contains key financial highlights (Q3 pre-tax results, operating expenses, cash) and operational updates for a specific three-month period (Q3 2022). This structure aligns perfectly with an Interim/Quarterly Report (IR). It is not a brief announcement of results (ER) because it contains detailed financial figures and operational narratives, nor is it a full Annual Report (10-K). The presence of a webcast/Q&A detail suggests it might accompany an Earnings Release, but the content itself is the comprehensive quarterly summary, making IR the most accurate classification. Q3 2022
2022-10-26 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.